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In this issue of Developmental Cell, Dhawan et al. (2011) show that deletion of theDnmt1 DNAmethyltransfer-
ase gene in pancreatic insulin-producing cells makes these cells convert into glucagon-producing cells. This
suggests that manipulation of a general epigenetic mechanism may be used to redirect cell fates.All cells within an organism harbor virtu-
ally identical genomes. Each cell type,
however, has a unique epigenome, with
specific genome-wide patterns of DNA
methylation, histone modifications, tran-
scription factor binding, and chromatin
compaction that determine which regions
are transcribed. Epigenetic marks are
dynamically placed or removed in a
lineage-specific fashion during embryonic
development, and ultimately maintain
cellular identities. For years, the idea that
one could modify epigenetic memory
in a differentiated cell to manipulate its
cell-specific fate has excited the imagina-
tions of many investigators. The reality,
however, is that there are not many exam-
ples in which this has been conclusively
demonstrated.
Dhawan et al. (2011) now report
that ablation of the Dnmt1 DNA methyl-
transferase gene in insulin-producing
pancreatic b cells converts these cells
into glucagon-producing a-like cells.
Dnmt1 copies previously established
DNA methylation patterns during cell divi-
sion, thereby maintaining DNA methyla-
tion-dependent gene repression. Their
findings therefore show that a defect in
the maintenance of DNA methylation
interferes with the ability to retain the
identity of pancreatic b cells.
How can loss of a global epigenetic
mechanism lead to such a selective cell
fate transition? Dhawan et al. (2011) show
that this involves the derepression of Arx,
a transcription factor that specifies a cell
differentiation in embryonic pancreatic
endocrine progenitors (Collombat et al.,
2003). Earlier studies have shown that if
Arx is misexpressed in adult b cells, these
cells turn into a cells (Collombat et al.,
2007). Dhawan et al. (2011) now show that
the upstream region of Arx is DNA methyl-ated in b cells and that deletion of Dnmt1
in b cells causes reducedDNAmethylation
and derepression of Arx, thus providing
a plausible mechanism for their conversion
into glucagon-producing cells.
Earlier attempts to removeDNAmethyl-
ation in differentiated cells have not
necessarily led to similar changes in cell
identity (Feng et al., 2010a). The results
reported by Dhawan et al. (2011) indicate
that b cells possess a repertoire of
transcription factors that enable
the activation of Arx when DNA methyla-
tion is removed. They also imply that the
b cell epigenome is permissive of reprog-
ramming to a cells. Consistent with this
notion, adult a cells were shown to
convert to b cells after complete b cell
ablation (Thorel et al., 2010). Such results
may reflect the common developmental
origin of a and b cells, given that cells
that have a shared developmental origin
also tend to share repressive epigenetic
programs that provide a compatible envi-
ronment for cell fate interconversions (van
Arensbergen et al., 2010).
Dhawan et al. (2011) then go on to
show that DNA methylation at the Arx
promoter causes recruitment of the
methyl-DNA binding protein MeCP2,
which in turn recruits PRMT6, an enzyme
that catalyzes the methylation of Arginine
2 on histone H3. This modification has
beenpreviously associatedwith transcrip-
tional silencing, thus pointing to a novel
mechanism whereby DNA methylation
may promote transcriptional repression.
The results therefore identify DNAmethyl-
ation and PRMT6-mediated histone argi-
nine methylation as contributors to the
stable repression of inappropriate genes,
thereby enabling long-term maintenance
of cell identity despite the diverse pertur-
bations associated with cell proliferation.Developmental CelInterestingly, the Arx promoter is also
enriched in another repressive histone
modification in b cells, namely trimethy-
latedLysine27onhistoneH3,ahallmarkof
Polycomb-mediated repression (van
Arensbergen et al., 2010). In fact, most
promoters of genes that encode for devel-
opmental regulators such as Arx contain
CpG islands that are spared from DNA
methylation (Straussman et al., 2009).
This class of genes is instead typically
repressed by Polycomb Group Com-
plexes (Margueron and Reinberg, 2011).
The studies from Dawhan et al. (2011)
suggest that the Arx gene is somewhat
unique in that it is not only controlled by
DNA methylation, but even exhibits DNA
methylation in the CpG island located in
its proximal promoter region.
This raises the questionofwhether Poly-
comb- and DNA methylation-dependent
mechanisms play different roles in repres-
sing Arx. Interestingly, the cell fate
changes reported by Dhawan et al. (2011)
are not observed until after a prolonged
8-month period, even though the Dnmt1
genestarts to be deleted as soon as b cells
are formed during embryogenesis. This
delay is, in part, attributable to the amount
of time needed for b cell proliferation to
gradually dilute out the DNA methylation
established prior to deletion of themainte-
nance of methyltransferase activity. How-
ever, it is also plausible that other mecha-
nisms, such as Polycomb-mediated
silencing, are important for Arx repression
during early specification of b cells,
whereas DNA methylation is necessary to
maintain repression in the adult differenti-
ated b cell.
The results reported by Dhawan et al.
(2011) have potential implications for
ongoing efforts to develop new regenera-
tive strategies. There is now considerablel 20, April 19, 2011 ª2011 Elsevier Inc. 411
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Previewsinterest in learning how different cell types
might be transformed into insulin-pro-
ducing b cells to treat Type 1 diabetes,
which results from autoimmune destruc-
tion of b cells. Although Dhawan et al.
(2011) reveal a potential mechanism to
generate a cells, an analogous strategy
might serve to make new b cells. A recent
report showed that misexpression of
the b cell regulator Pax4 in a cells can
promote their differentiation into b cells
(Collombat et al., 2009). It is therefore
possible that the deletion of Dnmt1 in
a cells might reactivate Pax4, thereby
promoting the transformation of a cells
into b cells. Nonetheless, several funda-
mental questions remain to be solved. For
example, a reprogramming strategy will
require a demonstration that cellular plas-
ticity can also be altered after conditional
deletion of Dnmt1 in adult cells, rather
than in embryonic b cells as reported by
Dhawan et al. (2011). In addition, cells412 Developmental Cell 20, April 19, 2011 ª2that lack a fundamental repressivemecha-
nism may potentially suffer from delete-
rious functional consequences andpheno-
typic instability. Earlier studies, for
example, have shown that DNA methyla-
tion-deficient forebrain neurons exhibit
abnormal gene expression patterns as
well as functional defects (Feng et al.,
2010a). These considerations notwith-
standing, the data from Dhawan et al.
(2011) provide a strong rationale to test
genetic or chemical perturbations of
repressive epigenetic mechanisms in
regenerative medicine.
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The acquisition of a lumen is an essential step in vascularmorphogenesis. In this issue ofDevelopmental Cell,
Xu et al. (2011) show that the small GTPase Rasip is a critical regulator of cytoskeleton dynamics and cell
adhesion, which together drive the emergence of vascular lumens.The vascular system consists of a series
of interconnecting ducts responsible for
the transport of blood and the trafficking
of immune cells. Understanding the
processes that regulate the acquisition,
maintenance, and remodeling of vascular
lumens is thus essential to build concrete
knowledge of vascular development and
function. Unlike lumen formation in
epithelial tubes, the identification of the
molecular players that regulate tube
morphogenesis by endothelial cells has
lagged behind other advances in vascular
biology. In the last decade, genetic
models in zebrafish and mice and inge-
nious in vitro systems that recapitulate
vascular morphogenesis have beendeveloped. The combination of these
systems has paved the way toward initial
characterization of the process by which
vessels gain lumens (Iruela-Arispe and
Davis, 2009). In this issue of Develop-
mental Cell, Xu et al. (2011) report findings
that add to the understanding of lumen
formation.
In vitro studies using three-dimensional
systems contributed significantly to the
body of knowledge regarding vascular
invasion and lumen formation. These
studies brought to light three categories
of molecules: regulators of cytoskeletal
dynamics, polarity proteins, and adhesion
receptors. In particular, it was found that
lumen formation requires integrin sig-naling, activation of Cdc42, Rac1, pak2/
4, Raf kinases, and the Par3/Par6/atypical
PKC complex (Koh et al., 2008, 2009).
More recently, our knowledge of
vascular lumen formation has been ex-
panded through the serendipitous explo-
ration of transgenic mutants. Deletion of
b1 integrin in the endothelial cell compart-
ment resulted in disruption of endothelial
cell polarity and arrest of lumen formation
(Zovein et al., 2010). Because the deletion
occurred by midgestation (E10.5–14.5),
removal of b1 integrin was found to
manifest differently in newer vessels and
in established endothelium. Loss of b1
integrin in the established endothelium
resulted in endothelial stratification and
